Skip Navigation


Cardiovascular Research Advance Access first published online on February 5, 2009
This version [Corrected Proof] published online on February 26, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp048
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
82/3/532    most recent
cvp048v2
cvp048v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Houard, X.
Right arrow Articles by Michel, J.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houard, X.
Right arrow Articles by Michel, J.-B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.

Mediators of neutrophil recruitment in human abdominal aortic aneurysms

Xavier Houard1, Ziad Touat1, Véronique Ollivier1, Liliane Louedec1, Monique Philippe1, Uriel Sebbag2, Olivier Meilhac1, Patrick Rossignol3 and Jean-Baptiste Michel1,*

1 INSERM U698, Cardiovascular Haematology, Bio-Engineering and Remodelings, Paris 7 Denis Diderot University, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, F-75877 Paris Cedex 18, France
2 Centre Cardiologique du Nord, 32–36 rue des Moulins Gémeaux, F-93207 Saint Denis Cedex, France
3 Centre d’Investigation Clinique de Nancy CIC-P 9501, INSERM, CHU de Nancy, Nancy-University, F-54201 Dommartin-lès-Toul, France

* Corresponding author. Tel: +331 40 25 86; fax: +331 40 25 86 02.E-mail address: jean-baptiste.michel{at}inserm.fr

Aims: Neutrophils/platelet interactions are involved in abdominal aortic aneurysm (AAA). The intraluminal thrombus (ILT) is a human model of platelet/neutrophil interactions. The present study focused on mediators involved in neutrophil recruitment in AAA.

Methods and results: Conditioned media from luminal, intermediate, and abluminal layers of 29 human ILTs were analysed for neutrophil markers [elastase/{alpha}1-antitrypsin and MMP9/NGAL complexes, myeloperoxidase (MPO), and {alpha}-defensin peptides], RANTES, platelet factor 4 (PF4), and interleukin-8 (IL-8). Their time-dependent release into serum from clots generated in vitro and their plasma concentrations in AAA patients and controls were determined. Immunohistochemistry for neutrophils, platelets, IL-8, PF4, and RANTES on AAA sections was performed; and molecules involved in ILT neutrophil chemotactic function were analysed in vitro. Neutrophils and platelets colocalized in the luminal layer of the thrombus. Consistently, neutrophil markers and platelet-derived RANTES and PF4 were released predominantly by the luminal thrombus pole, where their concentrations were significantly correlated. The luminal ILT layer was also the main source of IL-8, whose immunostaining colocalized with neutrophils. All were also released time dependently from clots and were increased in plasma of AAA patients. Luminal ILT layers displayed potent neutrophil chemotactic activity in vitro, which was inhibited by RANTES- and IL-8-blocking antibodies as well as by reparixin, an antagonist of the IL-8 receptors CXCR1 and CXCR2.

Conclusion: Taken together, these results suggest that platelet-derived RANTES and neutrophil-derived IL-8 are involved in attracting neutrophils to the luminal layer of AAA ILT.

KEYWORDS Intraluminal thrombus; Interleukin-8; RANTES; PF4; MMP9/NGAL; MPO; Elastase/{alpha}1-antitrypsin; {alpha}-Defensins

Time for primary review: 34 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.